Antibiotic utilisation in community practices: guideline concurrence and prescription necessity

Pharmacoepidemiology and Drug Safety
Susan JelinskiJames Hutchinson

Abstract

To evaluate the indications, concurrence with prescribing guidelines and potential necessity for antibiotic (AB) prescriptions written in community practice. We reviewed the charts of all patients with infection-related illnesses seen by family physicians during two random days of regular practice between 1 Oct 1997 and 30 Jan 1998. Guideline concurrence of AB prescribing was assessed using regional AB prescribing guidelines. Likelihood of AB indication for respiratory tract infections was assessed using published clinical practice guidelines for determination of likely viral versus bacterial etiology. Of 4218 visits captured, 949 (22%) were for newly acquired infections. Sixty four percent (n=604) of consultations for newly acquired infections resulted in an AB prescription. Based on the doctors' diagnoses, 61% of AB prescriptions were concurrent with prescribing guidelines, 10% were for the wrong drug, 20% were not indicated and in 10% of cases a lower line AB was available. For respiratory tract infections, 12% of these infections were likely bacterial, whereas the physicians determined that 56% were bacterial. A large proportion of ABs administered in community practices were not in concurrence with community AB prescribing...Continue Reading

References

Feb 1, 1992·BMJ : British Medical Journal·C P Bradley
Jun 1, 1991·The Journal of Infectious Diseases·H M BlumbergI K Wachsmuth
Jan 1, 1989·Scandinavian Journal of Infectious Diseases·H FriisR Vejlsgaard
Jan 18, 1995·JAMA : the Journal of the American Medical Association·L F McCaig, J M Hughes
Dec 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H SeppäläP Huovinen
Jan 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B R LevinF M Stewart
Jan 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G H MillerK J Shaw
Sep 25, 1997·JAMA : the Journal of the American Medical Association·R GonzalesM A Sande
Nov 14, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D N WilliamsW A Craig
Jan 27, 1998·Archives of Family Medicine·A G Mainous, W J Hueston
Feb 18, 1998·The Journal of Infectious Diseases·D GuillemotE Eschwège
Feb 18, 1998·Journal of Clinical Microbiology·M J MäkeläP Arstila
Feb 19, 1998·Journal of Clinical Epidemiology·D GuillemotE Eschwège
Mar 27, 1998·JAMA : the Journal of the American Medical Association·A C NyquistM A Sande
May 23, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G D Campbell, R Silberman
Sep 4, 1998·BMJ : British Medical Journal·E A Belongia, B Schwartz
Sep 12, 1998·Journal of General Internal Medicine·R GonzalesJ F Steiner
Feb 2, 1999·Pediatrics·H BauchnerJ O Klein
Feb 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·D J AustinR M Anderson
Jan 19, 2000·Medical Decision Making : an International Journal of the Society for Medical Decision Making·W J McIsaac, C C Butler
Sep 12, 2000·The Journal of Antimicrobial Chemotherapy·D T SteinkeP G Davey
Mar 20, 2001·Annals of Internal Medicine·R GonzalesUNKNOWN American College of Physicians-American Society of Internal Medicine
Mar 20, 2001·Annals of Internal Medicine·J M HicknerUNKNOWN Infectious Diseases Society of America
Mar 20, 2001·Annals of Internal Medicine·R J CooperUNKNOWN Centers for Disease Control
Mar 20, 2001·Annals of Internal Medicine·R GonzalesUNKNOWN Infectious Diseases Society of America
Jun 1, 2001·Annals of Emergency Medicine·R GonzalesUNKNOWN Centers for Disease Control and Prevention
Jun 1, 2001·Annals of Emergency Medicine·J M HicknerUNKNOWN Centers for Disease Control and Prevention
Jun 1, 2001·Annals of Emergency Medicine·R J CooperUNKNOWN Centers for Disease Control and Prevention
Jun 1, 2001·Annals of Emergency Medicine·R GonzalesUNKNOWN Centers for Disease Control and Prevention
Apr 10, 2004·Pharmacoepidemiology and Drug Safety·J P Connolly, H McGavock

❮ Previous
Next ❯

Citations

Jul 23, 2013·Enfermedades infecciosas y microbiología clínica·Rocío Fernández-UrrusunoM Carmen Montero-Balosa
Oct 27, 2007·The Lancet Infectious Diseases·Jarold L CosbyChristopher C Butler
Dec 15, 2010·Atencion primaria·M Catalina SernaPere Godoy
Jul 22, 2005·The Journal of Antimicrobial Chemotherapy·Annemiek E AkkermanTheo J M Verheij
Sep 13, 2005·The Journal of Antimicrobial Chemotherapy·Annemiek E AkkermanTheo J M Verheij
Sep 13, 2007·Forschende Komplementärmedizin = Research in Complementary Medicine·Elke JeschkeHarald Matthes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.